ESC 365 - The ORION Program - Rationale and emerging evidence

ESC Premium Access

The ORION Program - Rationale and emerging evidence

Session: The ORION Program - What to look for in ORION-11

Topic: Trial Design

Speaker: Doctor D. Kallend (Zurich, CH)

Sponsored by the Medicines Company

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor David Kallend

The Medicines Company, Zurich (Switzerland)

1 presentation

1 follower

5 more presentations in this session

Welcome and introductions.

Speaker: Doctor B. Berkowitz (New York, US)

Atherosclerotic cardiovascular disease management has made significant progress but may have stalled recently.

Speaker: Doctor C. Gibson (Boston, US)

LDL-C and outcomes: Implementing 21st century cardiovascular trials

Speaker: Professor L. Bowman (Oxford, GB)

Another PCSK-9 therapy?

Speaker: Professor R. Wright (Rochester, US)

Approaches to critically assess the evidence. A checklist for ORION-11

Speaker: Doctor C. Gibson (Boston, US)

Access the full session

The ORION Program - What to look for in ORION-11

Speakers: Doctor D. Kallend, Doctor B. Berkowitz, Doctor C. Gibson, Professor L. Bowman, Professor R. Wright...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources